Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Sales/Fixed Asset

    Back to All Ratios
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 2.452.692.872.683.24

What is the latest Sales/Fixed Asset ratio of WINDLAS BIOTECH ?

The latest Sales/Fixed Asset ratio of WINDLAS BIOTECH is 2.45 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20252.45
Mar20242.69
Mar20232.87
Mar20222.68
Mar20213.24

How is Sales/Fixed Asset of WINDLAS BIOTECH Trending?

Years Sales/Fixed Asset % Change
Mar2025 2.45
-8.92
Mar2024 2.69
-6.27
Mar2023 2.87
7.09
Mar2022 2.68
-17.28
Mar2021 3.24 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Sales/Fixed Asset ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,653.0 Cr -0.5% -2.4% 0.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-0.5%

-2.4%

0.7%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses